Vivera Pharmaceuticals Names Dr. Bobby W. Sandage, Jr. to Company’s Board of Advisors
Esteemed pharmaceutical expert joins innovative Newport Beach pharmaceutical companyin pursuit of breakthrough medical developments NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company, has welcomed Dr. Bobby W. Sandage, Jr. to the Company’s Board of Advisors. With nearly four decades of pharmaceutical experience in drug development, regulatory affairs and life sciences venture […]
Vivera Pharmaceuticals Granted Allowance for ZICOH® Patent
NEWPORT BEACH, Calif.– Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent for ZICOH®. Designed to better facilitate patient-provider interactions and play a role in reducing prescription opioid abuse, the ZICOH® device and its software are designed to enhance prescription compliance from manufacturer to patient. According to the […]
Vivera Pharmaceuticals Welcomes Farah Al Qaissieh as Neurosciences Ambassador
NEWPORT BEACH, Calif.– Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company, has named Farah Al Qaissieh to the Ambassador Board of its Neurosciences Division. As an ambassador, Ms. Al Qaissieh will serve a critical role in supporting and guiding the expansion of Vivera’s focus to include psychiatric and neurological therapies for patients worldwide, beginning with […]
Vivera Attends StutterFEST
Vivera is excited to attend StutterFEST 2021 this Saturday, May 8! Hosted by the World Stuttering Network, StutterFEST is a 20-hour celebration of the stuttering community featuring support group presentations, keynote speakers, a research symposium, and more! With presentations by our Chief Neurosciences Advisor, Dr. Gerald Maguire, and Neurosciences Ambassador, Ms. Farah Al Qaissieh of […]
TABMELT® Granted Patent Rights in Russia, Expanding Vivera Global Licensing
NEWPORT BEACH, Calif., Feb. 25, 2021 /PRNewswire/ — Vivera Pharmaceuticals, Inc., is pleased to announce the expansion of its exclusive global licensing of the novel TABMELT® platform to Russia. The latest TABMELT® patent approval comes as the Company begins to expand its pharmaceutical offerings into neuroscience, and joins Canada, the United Kingdom, and Australia as […]
Vivera Pharmaceuticals and Burkhan Group Announce New COVID-19 Testing Initiative
NEWPORT BEACH, Calif., Jan. 25, 2021 /PRNewswire/ — Vivera Pharmaceuticals, in partnership with Burkhan Group, is excited to announce a new testing initiative in Southern California. Together, the two are paving the way for easier access to rapid testing as area businesses develop back to work protocols. With Vivera’s suite of lower cost COVID-19 testing, […]
Vivera Pharmaceuticals Announces $440 Million in Backing by JR Dallas Wealth Management
NEWPORT BEACH, Calif., Nov. 25, 2020 /PRNewswire/ — Vivera Pharmaceuticals and Burkhan World today announce financial backing by JR Dallas Wealth Management in support of Vivera’s global growth strategies. This ongoing partnership will provide financial services – including debt and equity backing – for the purchase and distribution of Vivera’s innovative testing and expansive medical […]
Vivera Pharmaceuticals Welcomes Gerald A. Maguire, MD to Advisory Board
NEWPORT BEACH, Calif., Nov. 24, 2020 /PRNewswire/ — Vivera Pharmaceuticals is pleased to announce the appointment of Dr. Gerald A. Maguire, Professor and Chair of Psychiatry and Neuroscience at the University of California, Riverside School of Medicine, to the Company’s advisory board as the Chief Advisor of Vivera’s new Neurosciences Division. As a world-renowned researcher […]
Vivera Pharmaceuticals Partners with EcoGroup USA in the Distribution of its BioZone Sanitizing Stations
NEWPORT BEACH, Calif., Nov. 18, 2020 /PRNewswire/ — Vivera Pharmaceuticals is excited to announce a distribution partnership with EcoGroup USA for Vivera’s BioZone, an advanced access control device intended for sanitization in high occupancy settings. BioZone is designed to combine facial recognition, integrated biometrics, and a hospital grade FDA and EPA approved organic sanitization mist […]
Vivera Pharmaceuticals Selected to Screen Travellers to the UAE for COVID-19
NEWPORT BEACH, Calif., Oct. 7, 2020 /PRNewswire/ — Vivera Pharmaceuticals has been selected by Pure Health, the largest laboratory network in the UAE, to test airline passengers flying into the United Arab Emirates in accordance with the UAE’s requirement for travelers to prove they are not infected with COVID-19. Pure Health has been appointed by […]
